268 related articles for article (PubMed ID: 27189718)
1. Prostate cancer glands with cribriform architecture and with glomeruloid features should be considered as Gleason pattern 4 and not pattern 3.
Minardi D; Mazzucchelli R; Scarpelli M; Massari F; Ciccarese C; Lopez-Beltran A; Cheng L; Montironi R
Future Oncol; 2016 Jun; 12(12):1431-3. PubMed ID: 27189718
[No Abstract] [Full Text] [Related]
2. SOCS3 Immunohistochemical Expression Seems to Support the 2005 and 2014 International Society of Urological Pathology (ISUP) Modified Gleason Grading System.
Pierconti F; Martini M; Cenci T; Petrone GL; Ricci R; Sacco E; Bassi PF; Larocca LM
Prostate; 2017 May; 77(6):597-603. PubMed ID: 28144985
[TBL] [Abstract][Full Text] [Related]
3. Controversial issues in Gleason and International Society of Urological Pathology (ISUP) prostate cancer grading: proposed recommendations for international implementation.
Srigley JR; Delahunt B; Samaratunga H; Billis A; Cheng L; Clouston D; Evans A; Furusato B; Kench J; Leite K; MacLennan G; Moch H; Pan CC; Rioux-Leclercq N; Ro J; Shanks J; Shen S; Tsuzuki T; Varma M; Wheeler T; Yaxley J; Egevad L
Pathology; 2019 Aug; 51(5):463-473. PubMed ID: 31279442
[TBL] [Abstract][Full Text] [Related]
4. The 2014 International Society of Urological Pathology (ISUP) Consensus Conference on Gleason Grading of Prostatic Carcinoma: Definition of Grading Patterns and Proposal for a New Grading System.
Epstein JI; Egevad L; Amin MB; Delahunt B; Srigley JR; Humphrey PA;
Am J Surg Pathol; 2016 Feb; 40(2):244-52. PubMed ID: 26492179
[TBL] [Abstract][Full Text] [Related]
5. International Society of Urological Pathology (ISUP) grading of prostate cancer - An ISUP consensus on contemporary grading.
Egevad L; Delahunt B; Srigley JR; Samaratunga H
APMIS; 2016 Jun; 124(6):433-5. PubMed ID: 27150257
[TBL] [Abstract][Full Text] [Related]
6. Prostate cancer: from Gleason scoring to prognostic grade grouping.
Montironi R; Santoni M; Mazzucchelli R; Burattini L; Berardi R; Galosi AB; Cheng L; Lopez-Beltran A; Briganti A; Montorsi F; Scarpelli M
Expert Rev Anticancer Ther; 2016; 16(4):433-40. PubMed ID: 27008205
[TBL] [Abstract][Full Text] [Related]
7. Prognostic Significance of Percentage and Architectural Types of Contemporary Gleason Pattern 4 Prostate Cancer in Radical Prostatectomy.
Choy B; Pearce SM; Anderson BB; Shalhav AL; Zagaja G; Eggener SE; Paner GP
Am J Surg Pathol; 2016 Oct; 40(10):1400-6. PubMed ID: 27379821
[TBL] [Abstract][Full Text] [Related]
8. From Gleason to International Society of Urological Pathology (ISUP) grading of prostate cancer.
Samaratunga H; Delahunt B; Yaxley J; Srigley JR; Egevad L
Scand J Urol; 2016 Oct; 50(5):325-9. PubMed ID: 27415753
[TBL] [Abstract][Full Text] [Related]
9. [The 2014 consensus conference of the ISUP on Gleason grading of prostatic carcinoma].
Kristiansen G; Egevad L; Amin M; Delahunt B; Srigley JR; Humphrey PA; Epstein JI;
Pathologe; 2016 Feb; 37(1):17-26. PubMed ID: 26809207
[TBL] [Abstract][Full Text] [Related]
10. Usual and unusual histologic patterns of high Gleason score 8 to 10 adenocarcinoma of the prostate in needle biopsy tissue.
Gottipati S; Warncke J; Vollmer R; Humphrey PA
Am J Surg Pathol; 2012 Jun; 36(6):900-7. PubMed ID: 22367295
[TBL] [Abstract][Full Text] [Related]
11. Gleason and Fuhrman no longer make the grade.
Delahunt B; Egevad L; Samaratunga H; Martignoni G; Nacey JN; Srigley JR
Histopathology; 2016 Mar; 68(4):475-81. PubMed ID: 26266664
[TBL] [Abstract][Full Text] [Related]
12. Evolution, controversies and the future of prostate cancer grading.
Egevad L; Delahunt B; Yaxley J; Samaratunga H
Pathol Int; 2019 Feb; 69(2):55-66. PubMed ID: 30694570
[TBL] [Abstract][Full Text] [Related]
13. Validation of International Society of Urological Pathology (ISUP) grading for prostatic adenocarcinoma in thin core biopsies using TROG 03.04 'RADAR' trial clinical data.
Delahunt B; Egevad L; Srigley JR; Steigler A; Murray JD; Atkinson C; Matthews J; Duchesne G; Spry NA; Christie D; Joseph D; Attia J; Denham JW
Pathology; 2015 Oct; 47(6):520-5. PubMed ID: 26325671
[TBL] [Abstract][Full Text] [Related]
14. Impact on the clinical outcome of prostate cancer by the 2005 international society of urological pathology modified Gleason grading system.
Dong F; Wang C; Farris AB; Wu S; Lee H; Olumi AF; McDougal WS; Young RH; Wu CL
Am J Surg Pathol; 2012 Jun; 36(6):838-43. PubMed ID: 22592143
[TBL] [Abstract][Full Text] [Related]
15. Prostate cancer with cribriform morphology: diagnosis, aggressiveness, molecular pathology and possible relationships with intraductal carcinoma.
Montironi R; Cimadamore A; Gasparrini S; Mazzucchelli R; Santoni M; Massari F; Cheng L; Lopez-Beltran A; Scarpelli M
Expert Rev Anticancer Ther; 2018 Jul; 18(7):685-693. PubMed ID: 29699428
[TBL] [Abstract][Full Text] [Related]
16. Comparative influence of cribriform growth and percent Gleason 4 in prostatic biopsies with Gleason 3+4 cancer.
Czaja RC; Tarima S; Wu R; Palagnmonthip W; Iczkowski KA
Ann Diagn Pathol; 2021 Jun; 52():151725. PubMed ID: 33610958
[TBL] [Abstract][Full Text] [Related]
17. Gleason grading: past, present and future.
Delahunt B; Miller RJ; Srigley JR; Evans AJ; Samaratunga H
Histopathology; 2012 Jan; 60(1):75-86. PubMed ID: 22212079
[TBL] [Abstract][Full Text] [Related]
18. The reasons behind variation in Gleason grading of prostatic biopsies: areas of agreement and misconception among 266 European pathologists.
Berney DM; Algaba F; Camparo P; Compérat E; Griffiths D; Kristiansen G; Lopez-Beltran A; Montironi R; Varma M; Egevad L
Histopathology; 2014 Feb; 64(3):405-11. PubMed ID: 24102975
[TBL] [Abstract][Full Text] [Related]
19. The prognostic significance of the 2014 International Society of Urological Pathology (ISUP) grading system for prostate cancer.
Samaratunga H; Delahunt B; Gianduzzo T; Coughlin G; Duffy D; LeFevre I; Johannsen S; Egevad L; Yaxley J
Pathology; 2015 Oct; 47(6):515-9. PubMed ID: 26325670
[TBL] [Abstract][Full Text] [Related]
20. Prostate cancer grading in 2018: limitations, implementations, cribriform morphology, and biological markers.
Montironi R; Cimadamore A; Cheng L; Lopez-Beltran A; Scarpelli M
Int J Biol Markers; 2018 Nov; 33(4):331-334. PubMed ID: 29945478
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
